Skip to content

To study the effect of Tablet Ayapon in the stoppage of blood from extraction socket of people without stopping Anti Platelet therapy in the patient who are in need of dental extraction

Clinical Evaluation of Efficacy of AYAPON Tablet as a Topical Haemostatic Agent in Patients on Anti-Platelet Therapy Requiring Dental Extraction-A Randomised Control Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077740
Enrollment
72
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20-I25- Ischemic heart diseases

Interventions

None listed

Sponsors

Dr HIMANSHU RAMTEKE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients on antiplatelet therapy

Exclusion criteria

Exclusion criteria: 1. Patients with impacted mandibular and maxillary molars requiring surgical extraction. 2. Patients with possible allergies or hypersensitivity to study drug and local anaesthesia and to drugs such as antibiotics and anti-inflammatory drugs. 3. Mentally challenged patients, pregnant women and Lactating mothers 4. Patients on corticosteroid therapy 5. Patients with reduced mouth opening due to conditions such as oral submucous fibrosis and hypoplastic mandible

Design outcomes

Primary

MeasureTime frame
1)To assess usefulness of pressure pack and Ayapon tablet to control bleeding following dental extraction in patients under anti-platelet therapy. 2)To compare efficacy of Ayapon tablet with suturing over extraction socket and pressure pack soaked in saline.Timepoint: patient is evaluated post extraction 45 mins, 1st , 2nd , 3rd , 5th and 7th day.

Secondary

MeasureTime frame
1)To document the need of haemostatic agent in patient on antiplatelet therapy for dental extraction 2) To document the incidence of swelling or dry socket at the extraction site. 3)To assess any adverse effect associated with the use of Ayapon tablet at extraction site. Timepoint: patient is evaluated post extraction 45 mins, 1st , 2nd , 3rd , 5th and 7th day.

Countries

India

Contacts

Public ContactDr Mohan Deshpande

Nair Hospital Dental College

mdd.nhdcos@gmail.com9820474383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026